Literature DB >> 27407031

Synthesis and biological evaluation of 3-substituted 5-benzylidene-1-methyl-2-thiohydantoins as potent NADPH oxidase (NOX) inhibitors.

Yun Soo Bae1, Sun Choi2, Jung Jae Park3, Jung Hee Joo1, Minghua Cui2, Hyunsung Cho3, Won Jae Lee4, Sang Hyup Lee5.   

Abstract

We report the synthesis of novel 3-substituted 5-benzylidene-1-methyl-2-thiohydantoins 3, and their biological evaluation using NADPH oxidase (NOX) 1 and 4. Based on structural and pharmacophore analyses of known inhibitors such as hydroxypyrazole 2, we envisioned interesting 2-thiohydantoin compounds, 3-substituted 5-benzylidene-1-methyl-2-thiohydantoins 3 that would be expected to well match the structural features in 2. Efficient synthesis of eighteen target compounds 3 were achieved through the synthetic pathway of 4→11→3, established after consideration of several plausible synthetic pathways. The inhibitory activities of compounds 3 against NOX 1 and 4 were measured, with some of the target compounds showing similar or higher activities compared with reference 2; in particular, compounds 3bz, 3cz, and 3ez were found to be promising inhibitors of both NOX 1 and 4 with modest isozyme selectivities, which highlights the significance of the 2-thiohydantoin substructure for inhibition of NOX 1 and 4. This marks the first time these compounds have been applied to the inhibition of NOX enzymes.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Aluminum chloride; Benzylidene; NADPH oxidase (NOX); Thiohydantoin

Mesh:

Substances:

Year:  2016        PMID: 27407031     DOI: 10.1016/j.bmc.2016.06.056

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  1 in total

1.  Synthesis of thia- and thioxo-tetraazaspiro[4.4]nonenones from nitrile imines and arylidenethiohydantoins.

Authors:  Issa Yavari; Zohreh Taheri; Sara Sheikhi; Samira Bahemmat; Mohammad R Halvagar
Journal:  Mol Divers       Date:  2020-02-25       Impact factor: 2.943

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.